Sienna Biopharmaceuticals, Inc.
SNNAQ · OTC
9/30/2019 | 6/30/2019 | 3/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,970 | -$8,264 | -$16,382 | -$19,335 |
| Dep. & Amort. | $36 | $37 | $39 | $40 |
| Deferred Tax | $26,423 | $1 | $14 | $0 |
| Stock-Based Comp. | $1,406 | $871 | $1,533 | $1,309 |
| Change in WC | -$8,279 | -$1,213 | -$3,020 | -$1,903 |
| Other Non-Cash | -$33,460 | $151 | $5,047 | $4,290 |
| Operating Cash Flow | -$17,844 | -$8,417 | -$12,769 | -$15,599 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$4 | -$6 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$4 | -$6 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $13 |
| Stock Issued | $0 | $452 | $21,442 | $262 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$20,000 | $0 | -$16 | $18 |
| Financing Cash Flow | -$20,000 | $452 | $21,426 | $293 |
| Forex Effect | $1 | $3 | -$10 | -$137 |
| Net Chg. in Cash | -$37,843 | -$7,962 | $8,643 | -$15,449 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $49,388 | $57,350 | $48,707 | $64,156 |
| End Cash | $11,545 | $49,388 | $57,350 | $48,707 |
| Free Cash Flow | -$17,844 | -$8,417 | -$12,773 | -$15,605 |